Skip to main content
Premium Trial:

Request an Annual Quote

Erasmus and Windber to Co-develop Data Warehousing Tool

NEW YORK, Feb. 7 (GenomeWeb News) - Erasmus University Medical Center and the Windber Research Institute will develop a translational medicine data warehousing product for clinical, imaging, and proteomic and genomic data, WRI announced yesterday.


The combined warehouse will run on Oracle and InforSense technologies, WRI said in a statement.


The nonprofit WRI, based in Pennsylvania, has a databank housing more than 19,000 breast disease samples as part of an existing relationship with Walter Reed's clinical breast care program.


Erasmus, based in Rotterdam, the Netherlands, uses Affymetrix microarrays in many disease research areas, including pediatric and geriatric studies.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.